Pharmacoeconomics: Incorporating Value and Cost Assessments into Clinical Practice
The goal of this online program is to support clinicians and decision-makers in adopting and/or recommending specific treatments based on pharmacoeconomic principles for best efficiency of health systems with positive patient outcomes. The program is intended to increase healthcare practitioners’ comfort and confidence in knowledgably discussing and recommending medications that provide value and reduce costs.
This program has received an educational grant or in-kind support from Pharmascience
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 2.00 CEUs.
Marc Evans, MB, Bch, FRCP (UK), MD (Wales)
Moe Abdallah, B.SC., B.SC.PHM., R.PH
Mai Alsaqa’aby, BPharm, MS
Upon completion of this continuing education program, participants will be better able to:
- Explain the key principles of value, inputs, outputs and incremental analysis when assessing competing healthcare products.
- Describe the main types of pharmacoeconomic evaluations, how they are conducted and when they are used.
- Explain the function of discounting and sensitivity analyses in pharmacoeconomic evaluations.
- Discuss special topics around assessing value in health including network meta-analyses, real world evidence, cost-effectiveness thresholds, budget impact analyses and expensive therapies for unique populations.
- Apply pharmacoeconomic principles to published pharmacoeconomic studies (CMA, CEA, CUA).